Johnson & Johnson

Johnson & Johnson News

Patient groups urge HealthMin to ‘discontinue’ J&J TB drug donations

J&J, earlier this month, announced that it would be providing 10,000 courses of bedaquiline, used to treat multi drug-resistant TB, “free of charge” to India through USAID in addition to the 10,000 courses it had committed before.

Johnson & Johnson's rejects lab report on baby shampoo, authorities want product off shelves

The company has strongly objected to the Jaipur-based Drug Testing Laboratory's findings that declared the shampoo allegedly contained formaldehyde.

Advertising

J&J baby care products: NCPCR summons officials of five states

Last month, Johnson & Johnson, had come under the scanner after the Rajasthan drugs control organisation red flagged two batches of the company’s baby shampoo for failing quality tests.

J&J baby shampoo samples fail quality test; company rejects findings

The Rajasthan Drugs Control Organisation's notice dated March 5 said that the samples of J&J's baby shampoo taken from two batches had failed the quality test as they contained "harmful ingredients".

California jury orders Johnson & Johnson to pay $29 million in latest talc cancer trial

The verdict, in California Superior Court in Oakland, marks the latest defeat for the healthcare conglomerate, which faces more than 13,000 talc-related lawsuits nationwide.

Pay Rs 74.5 lakh to patient with ‘faulty’ hip implant: Drug regulator tells Johnson & Johnson

Johnson & Johnson had marketed the ASR (articular surface replacement) implants in India through its subsidiary DePuy between 2004 and 2010.

Advertising

CDSCO asks J&J to show cause for advertisements using govt test results

The move comes nearly a week after the company issued a statement that CDSCO had found its baby powder asbestos-free.

‘J&J resumes production of baby powder in India after tests find no asbestos’

The Central Drugs Standard Control Organisation (CDSCO), India’s central drug regulatory body, that month seized samples of the product from J&J’s manufacturing plants in India to test for this ingredient.

#ImplantFiles: Johnson & Johnson implant patients object to compensation package

While raising the objection, patients pointed to how India does not issue disability certificates for metal ion poisoning, which is the main cause of the ASR implants being termed faulty.

Few of our facilities were visited by CDSCO, local FDA: Johnson & Johnson

The spokesperson of the firm said: “Johnson & Johnson’s baby powder is asbestos free and does not cause cancer.

Johnson & Johnson Videos

How Johnson & Johnson pushed another 'faulty' hip implant in India

What slipped under the radar is a story of how Johnson & Johnson used a loophole in US laws to push the product into the Indian market.

Advertising